ZIMMER BIOMET HOLDINGS, INC. Revenue From Contract With Customer Excluding Assessed Tax

• ZIMMER BIOMET HOLDINGS, INC. showed an increase of +7.2% in Revenue From Contract With Customer Excluding Assessed Tax from 2024 to 2025.
• This data is from ZIMMER BIOMET HOLDINGS, INC.'s annual report (Form 10-K), filed with the SEC on February 20, 2026.
• XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q1 2017: $1.97 billion | Q2 2017: $1.95 billion | Q3 2017: $1.81 billion | Q4 2017: $2.07 billion | Q1 2018: $2.02 billion | Q2 2018: $2.01 billion | Q3 2018: $1.84 billion | Q4 2018: $2.07 billion | Q1 2019: $1.98 billion | Q2 2019: $1.99 billion | Q3 2019: $1.89 billion | Q4 2019: $2.13 billion | Q1 2020: $1.78 billion | Q2 2020: $1.23 billion | Q3 2020: $1.93 billion | Q4 2020: $2.09 billion | Q1 2021: $1.60 billion | Q2 2021: $1.76 billion | Q3 2021: $1.69 billion | Q1 2022: $1.66 billion | Q2 2022: $1.78 billion | Q3 2022: $1.67 billion | Q1 2023: $1.83 billion | Q2 2023: $1.87 billion | Q3 2023: $1.75 billion | Q1 2024: $1.89 billion | Q2 2024: $1.94 billion | Q3 2024: $1.82 billion | Q1 2025: $1.91 billion | Q2 2025: $2.08 billion | Q3 2025: $2.00 billion.
• Over the full 10 years of available data (2016 to 2025), ZIMMER BIOMET HOLDINGS, INC.'s Revenue From Contract With Customer Excluding Assessed Tax has grown by 7.3%.
• Historical annual values: Fiscal year 2025: $8.23 billion | Fiscal year 2024: $7.68 billion | Fiscal year 2023: $7.39 billion | Fiscal year 2022: $6.94 billion | Fiscal year 2021: $6.83 billion | Fiscal year 2020: $6.13 billion | Fiscal year 2019: $7.98 billion | Fiscal year 2018: $7.93 billion | Fiscal year 2017: $7.80 billion | Fiscal year 2016: $7.67 billion.
• Data sourced from SEC EDGAR public filings as of August 9, 2026.

Last verified: August 9, 2026